Back to Agenda
[S34] The Present and Future of Utilization of AI and Digital Technology in Medicine Development and Healthcare Services -To Deliver Rational Medicine-
Session Chair(s)
Kazuhiro Kanmuri, PHD
Executive Officer, Head of Development Div., Tanabe Pharma Corporation, Japan
DIA Japan organized a symposium entitled “Cutting Edge Series - The Present and Future of Utilization of AI and Digital Technology in Drug Development -”. The key elements that become the driving force of continuous innovation promotion regardless of industries are: (1) promoting technological innovation as the core of innovation, (2) application technology in needs including commercialization, and assess a level of utility and improvement, (3) fostering talent with high potential and find experts, and connect them to promote further innovation. In this session, experts (engaging AI application using multi-omics and promoting education for coming AI and digital era) from academia, pharmaceutical companies, technology venders and regulators will be invited to share their insights and discuss how we contribute to deliver rational medicine.
Speaker(s)
Catherine CL Wong, PHD
Professor/Director, Peking University, Center for Precision Medicine MultiOmics Research, China
AI Empowers Biomarker Discoveries Using Multi-Omics Technologies
Hiroki Tsuruta, PHD
Associate Professor, Office of Academic and Industrial Innovation, Kobe University, Japan
Education Program for Value Creator Who Can Construct Bright Future in Kobe University and Future
Hiroyasu Sugihara
Manager, Direct Sales, Automation Anywhere Japan, Co., Ltd., Japan
Key Points for Introducing RPA in the Pharmaceutical Industry
Have an account?